Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Fellow, Harvard University Alley-Sheridan School of Government
Residency, Texas Heart Institute
Active Clinical Trials

PERIGON Pivotal Trial

NCT02088554


CoreValve High Risk Surgical Patients

NCT01240902

Publications

The fallacy of indexed effective orifice area charts to predict prosthesis-patient mismatch after prosthesis implantation
Vriesendorp, MD, Van Wijngaarden, RAFDL, Head, SJ, Kappetein, AP, Hickey, GL, Rao, V, Weissman, NJ, Reardon, MJ, Moront, MG, Sabik, JF & Klautz, RJM 2020, , European Heart Journal Cardiovascular Imaging, vol. 21, no. 10, pp. 1116-1122. https://doi.org/10.1093/ehjci/jeaa044

Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis
Arnold, SV, Chinnakondepalli, KM, Magnuson, EA, Reardon, MJ, Deeb, GM, Gleason, T, Yakubov, SJ, Cohen, DJ & Investigators, FTCUSPT 2020, , JAMA Cardiology. https://doi.org/10.1001/jamacardio.2020.4397

Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial)
Yakubov, SJ, Van Mieghem, NM, Reardon, MJ, Serruys, PW, Gada, H, Mumtaz, M, Deeb, GM, Kodali, S, George, I, Windecker, S, Kleiman, N, Chetcuti, SJ, Sanchez, C, Dauerman, HL, Li, S & Popma, JJ 2020, , American Journal of Cardiology, vol. 131, pp. 82-90. https://doi.org/10.1016/j.amjcard.2020.06.051

Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance
Zhan, Y, Debs, D, Khan, MA, Nguyen, DT, Graviss, EA, Khalaf, S, Little, SH, Reardon, MJ, Nagueh, S, Quiñones, MA, Kleiman, N, Zoghbi, WA & Shah, DJ 2020, , Journal of the American College of Cardiology, vol. 76, no. 11, pp. 1291-1301. https://doi.org/10.1016/j.jacc.2020.07.036

Renin-Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement
Goel, SS, Kleiman, NS, Zoghbi, WA, Reardon, MJ & Kapadia, SR 2020, , Journal of the American Heart Association, vol. 9, no. 18, pp. e016911. https://doi.org/10.1161/JAHA.120.016911

Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
Goel, K, OLeary, JM, Barker, CM, Levack, M, Rajagopal, V, Makkar, RR, Bajwa, T, Kleiman, N, Linke, A, Kereiakes, DJ, Waksman, R, Allocco, DJ, Rizik, DG, Reardon, MJ & Lindman, BR 2020, , Journal of the American Heart Association, vol. 9, no. 17, pp. e017075. https://doi.org/10.1161/JAHA.120.017075

Role of Teleproctoring in Challenging and Innovative Structural Interventions Amid the COVID-19 Pandemic and Beyond
Goel, SS, Greenbaum, AB, Patel, A, Little, SH, Parikh, R, Wyler von Ballmoos, MC, Lumsden, AB, Reardon, MJ & Kleiman, N 2020, , JACC: Cardiovascular Interventions, vol. 13, no. 16, pp. 1945-1948. https://doi.org/10.1016/j.jcin.2020.04.013

Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve
Attizzani, GF, Dallan, LAP, Markowitz, A, Yakubov, SJ, Deeb, GM, Reardon, MJ, Forrest, JK, Mangi, AA, Huang, J & Popma, JJ 2020, JACC: Cardiovascular Interventions, vol. 13, no. 15, pp. 1816-1824. https://doi.org/10.1016/j.jcin.2020.04.028

Safety, efficacy, and hemodynamic performance of a stented bovine pericardial aortic valve bioprosthesis: Two-year analysis
Dagenais, F, Moront, MG, Brown, WM, Reardon, MJ, Chu, MWA, Gearhart, E & Klautz, RJM 2020, , Journal of Thoracic and Cardiovascular Surgery, vol. 160, no. 2, pp. 371-381.e4. https://doi.org/10.1016/j.jtcvs.2019.07.132

Commentary: Black swan theory or just another bird sighting?
Lin, CH & Reardon, MJ 2020, , Journal of Thoracic and Cardiovascular Surgery, vol. 160, no. 2, pp. 510-511. https://doi.org/10.1016/j.jtcvs.2019.11.017

Transcatheter Mitral Valve Repair with MitraClip for Severe Mitral Regurgitation and Cardiogenic Shock During the COVID-19 Pandemic
Chitturi, KR, Faza, NN, Little, SH, Kleiman, NS, Reardon, MJ & Goel, SS 2020, , Cardiovascular Revascularization Medicine, vol. 21, no. 8, pp. 950-953. https://doi.org/10.1016/j.carrev.2020.05.030

First-in-Human Transfemoral Transseptal Mitral Valve Chordal Repair
Rogers, JH, Ebner, AA, Boyd, WD, Lim, S, Reardon, MJ, Smith, TW & Bolling, SF 2020, JACC: Cardiovascular Interventions, vol. 13, no. 11, pp. 1383-1385. https://doi.org/10.1016/j.jcin.2019.12.019

Invited Commentary
Atkins, MD & Reardon, MJ 2020, , Annals of Thoracic Surgery, vol. 109, no. 6. https://doi.org/10.1016/j.athoracsur.2019.09.037

Transcatheter Aortic Valve Replacement After Prior Mitral Valve Surgery: Results From the Transcatheter Valve Therapy Registry
Thourani, VH, Kelly, JJ, Cervantes, DG, Vemulapalli, S, Manandhar, P, Forcillo, J, Holmes, DR, Cohen, DJ, Kirtane, AJ, Kodali, SK, Leon, MB, Babaliaros, V, Waksman, R, Satler, LF, Shults, CC, Ben-Dor, I, Rogers, T, Kapadia, S, Reardon, MJ, Malaisrie, SC, Gleason, TG, Holper, EM, Bavaria, JE, Herrmann, HC, Szeto, WY, Carroll, JD & Mack, MJ 2020, , Annals of Thoracic Surgery, vol. 109, no. 6, pp. 1789-1796. https://doi.org/10.1016/j.athoracsur.2019.08.113

Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study
Evolut Low Risk LTI Substudy Investigators 2020, , Journal of the American College of Cardiology, vol. 75, no. 19, pp. 2430-2442. https://doi.org/10.1016/j.jacc.2020.03.022

Primary Cardiac Malignancies: The Need for a Multidisciplinary Approach and the Role of the Cardio-Oncologist
Lestuzzi, C & Reardon, MJ 2020, Journal of the American College of Cardiology, vol. 75, no. 18, pp. 2348-2351. https://doi.org/10.1016/j.jacc.2020.03.046

Association Between Institutional Mitral Valve Procedure Volume and Mitral Valve Repair Outcomes in Medicare Patients
Barker, CM, Reardon, MJ, Reynolds, MR & Feldman, TE 2020, , JACC: Cardiovascular Interventions, vol. 13, no. 9, pp. 1137-1139. https://doi.org/10.1016/j.jcin.2020.01.212

Commentary: To OAC or not to OAC? That is the question
Atkins, M & Reardon, MJ 2020, , Journal of Thoracic and Cardiovascular Surgery, vol. 159, no. 5, pp. 1740-1741. https://doi.org/10.1016/j.jtcvs.2019.04.103

Impact of Cardiac Cycle on Thoracic Aortic Geometry—Morphometric Analysis of Ecg Gated Computed Tomography
Zubair, MM, de Beaufort, HWL, Belvroy, VM, Schwein, A, Irshad, A, Mohamed, A, Gomez, LF, Chinnadurai, P, Nabi, F, Yang, EY, Trimarchi, S, Reardon, MJ & Bismuth, J 2020, , Annals of Vascular Surgery, vol. 65, pp. 174-182. https://doi.org/10.1016/j.avsg.2019.10.072

Commentary: Constant variability
Atkins, M & Reardon, MJ 2020, Journal of Thoracic and Cardiovascular Surgery, vol. 159, no. 4, pp. 1247-1248. https://doi.org/10.1016/j.jtcvs.2019.04.102